Question 1

What are the potential side effects of HRS-1167 and bevacizumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer clinical trial (NCT06308406). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer clinical trial (NCT06308406). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment schedule look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer clinical trial (NCT06308406). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific tests or monitoring I will need during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer clinical trial (NCT06308406). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or my condition worsens during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer clinical trial (NCT06308406). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my overall health and cancer status be monitored throughout the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer clinical trial (NCT06308406). Contact the study team or your healthcare provider for specific answers.

What this study is about